Biology Is Technology

Regular price €33.99
Quantity:
In stock with our UK publisher. 14-28 days
Delivery/Collection within 10-20 working days
14 days return policy Shipping & Delivery
A01=Robert H. Carlson
Age Group_Uncategorized
Age Group_Uncategorized
applications
applied
Author_Robert H. Carlson
automatic-update
bioengineering
bioethics
biological
biotech
biotechnology
case studies
Category1=Non-Fiction
Category=KCC
Category=KCCD
Category=PS
Category=TCB
cells
chemistry
COP=United States
Delivery_Delivery within 10-20 working days
development
eq_bestseller
eq_business-finance-law
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
eq_tech-engineering
ethics
experiments
genetically
genetics
genomes
gmos
innovation
Language_English
medical
modified
morality
organisms
PA=Available
Price_€20 to €50
PS=Active
regulation
research
science
softlaunch
synthetic
systems
tests

Product details

  • ISBN 9780674060159
  • Dimensions: 156 x 235mm
  • Publication Date: 15 Apr 2011
  • Publisher: Harvard University Press
  • Publication City/Country: US
  • Product Form: Paperback
  • Language: English
Secure checkout Fast Shipping Easy returns

Technology is a process and a body of knowledge as much as a collection of artifacts. Biology is no different—and we are just beginning to comprehend the challenges inherent in the next stage of biology as a human technology. It is this critical moment, with its wide-ranging implications, that Robert Carlson considers in Biology Is Technology. He offers a uniquely informed perspective on the endeavors that contribute to current progress in this area—the science of biological systems and the technology used to manipulate them.

In a number of case studies, Carlson demonstrates that the development of new mathematical, computational, and laboratory tools will facilitate the engineering of biological artifacts—up to and including organisms and ecosystems. Exploring how this will happen, with reference to past technological advances, he explains how objects are constructed virtually, tested using sophisticated mathematical models, and finally constructed in the real world.

Such rapid increases in the power, availability, and application of biotechnology raise obvious questions about who gets to use it, and to what end. Carlson’s thoughtful analysis offers rare insight into our choices about how to develop biological technologies and how these choices will determine the pace and effectiveness of innovation as a public good.

Robert H. Carlson is a Principal at Biodesic LLC.

More from this author